CSSP.F Stock Overview
Engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
NIOX Group Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.69 |
| 52 Week High | UK£0.75 |
| 52 Week Low | UK£0.69 |
| Beta | 0.77 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | 129.24% |
| Change since IPO | -85.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| CSSP.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -2.1% | -4.4% |
| 1Y | n/a | 2.1% | 2.5% |
Return vs Industry: Insufficient data to determine how CSSP.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how CSSP.F performed against the US Market.
Price Volatility
| CSSP.F volatility | |
|---|---|
| CSSP.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 9.1% |
| Market Average Movement | 7.7% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: CSSP.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CSSP.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 91 | Jonathan Emms | investors.niox.com |
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022.
NIOX Group Plc Fundamentals Summary
| CSSP.F fundamental statistics | |
|---|---|
| Market cap | US$315.13m |
| Earnings (TTM) | US$4.55m |
| Revenue (TTM) | US$55.91m |
69.3x
P/E Ratio5.6x
P/S RatioIs CSSP.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CSSP.F income statement (TTM) | |
|---|---|
| Revenue | UK£41.80m |
| Cost of Revenue | UK£11.60m |
| Gross Profit | UK£30.20m |
| Other Expenses | UK£26.80m |
| Earnings | UK£3.40m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0085 |
| Gross Margin | 72.25% |
| Net Profit Margin | 8.13% |
| Debt/Equity Ratio | 0% |
How did CSSP.F perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield154%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/22 14:04 |
| End of Day Share Price | 2025/04/11 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
NIOX Group Plc is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Julie Simmonds | Canaccord Genuity |
| Jens Lindqvist | Investec Bank plc (UK) |
| Richard Vosser | J.P. Morgan |